Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Wallach

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
JAMA|August 21, 2024
Surrogate Markers and Clinical Outcomes-ReplyJoshua D Wallach, Reshma Ramachandran, Joseph S Ross
The New England Journal of Medicine|December 8, 2025
Enhancing FDA Drug-Safety Surveillance - Beyond Releasing Daily Adverse-Event DataJoshua D Wallach, Joseph S Ross, Reshma Ramachandran
Clinical Trials (London, England)|June 7, 2018
The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generationJoshua D Wallach, Joseph S Ross, Huseyin Naci
JAMA|July 21, 2018
Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy DesignationJeremy Puthumana, Joshua D Wallach, Joseph S Ross
JAMA|November 21, 2018
Breakthrough Therapy Designation for New Drugs-ReplyJeremy Puthumana, Joshua D Wallach, Joseph S Ross
Journal of Clinical Epidemiology|October 19, 2017
Research, regulatory, and clinical decision-making: the importance of scientific integrityJoshua D Wallach, Gregg S Gonsalves, Joseph S Ross
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Autoimmune diseases and risk of non-Hodgkin lymphoma: A Mendelian randomisation studyXiaoting Shi, Joshua D Wallach, Xiaomei Ma, et al.
JAMA Internal Medicine|February 12, 2024
Hypothetical Assessments of Trial Emulations-ReplyGuneet S Janda, Joshua D Wallach, Joseph S Ross
Cancer Medicine|November 7, 2024
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation StudyXiaoting Shi, Joshua D Wallach, Xiaomei Ma, et al.
Plos Biology|November 21, 2018
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017Joshua D Wallach, Kevin W Boyack, John P A Ioannidis
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
JAMA|August 21, 2024
Surrogate Markers and Clinical Outcomes-ReplyJoshua D Wallach, Reshma Ramachandran, Joseph S Ross
The New England Journal of Medicine|December 8, 2025
Enhancing FDA Drug-Safety Surveillance - Beyond Releasing Daily Adverse-Event DataJoshua D Wallach, Joseph S Ross, Reshma Ramachandran
Clinical Trials (London, England)|June 7, 2018
The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generationJoshua D Wallach, Joseph S Ross, Huseyin Naci
JAMA|July 21, 2018
Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy DesignationJeremy Puthumana, Joshua D Wallach, Joseph S Ross
JAMA|November 21, 2018
Breakthrough Therapy Designation for New Drugs-ReplyJeremy Puthumana, Joshua D Wallach, Joseph S Ross
Journal of Clinical Epidemiology|October 19, 2017
Research, regulatory, and clinical decision-making: the importance of scientific integrityJoshua D Wallach, Gregg S Gonsalves, Joseph S Ross
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Autoimmune diseases and risk of non-Hodgkin lymphoma: A Mendelian randomisation studyXiaoting Shi, Joshua D Wallach, Xiaomei Ma, et al.
JAMA Internal Medicine|February 12, 2024
Hypothetical Assessments of Trial Emulations-ReplyGuneet S Janda, Joshua D Wallach, Joseph S Ross
Cancer Medicine|November 7, 2024
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation StudyXiaoting Shi, Joshua D Wallach, Xiaomei Ma, et al.
Plos Biology|November 21, 2018
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017Joshua D Wallach, Kevin W Boyack, John P A Ioannidis
Pageof 12